Peracetic acid for reuse of hemodialyzers clinical studies.
When Renalin was used for reprocessing, the incidences of headache and hypotension were reduced and no changes in serum chemistries were noted. Dialyzer appearance was superior to that achieved with formaldehyde but accompanied by decreases in clearance of urea, creatinine, vitamin B-12 and a fall in KUF. While long-term patient toxicity studies are not yet available, laboratory studies suggest potential problems with carcinogenicity similar to those erroneously attributed to formaldehyde. These data suggest that Renalin may be a suitable alternative to formaldehyde for reprocessing hemodialyzers.
D000085:Acetates / Q000009:adverse effects; D004203:Disinfection / Q000379:methods*; D005557:Formaldehyde / Q000009:adverse effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010463:Peracetic Acid / Q000009:adverse effects; D006435:Renal Dialysis / Q000379:methods*; D012306:Risk; D013242:Sterilization / Q000379:methods*
D000085:Acetates; D005557:Formaldehyde; D010463:Peracetic Acid